South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
Q: I saw an advertisement in a magazine for a needle-free insulin pen. Can you tell me more about how this works and is it ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...
After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 ...
Aspen Pharmacare Holdings Ltd, Africa’s largest drugmaker, has a deal with Novo to make human insulin vials in South Africa, with local commercial production starting soon. “We are just trying ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback